The clinical significance of microRNA-409 in pancreatic carcinoma and associated tumor cellular functions

References

• Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016 Nov 28;22(44):9694–9705.
   PubMed Web of Science ®Google Scholar
• Previdi MC, Carotenuto P, Zito D, et al. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know? Future Oncol. 2017 Feb;13(5):443–453.
   PubMed Web of Science ®Google Scholar
• Pancreatic Cancer: GV. Pathogenesis and diagnosis. Asian Pac J Cancer Prev. 2015;16(14):5619–5624.
   PubMedGoogle Scholar
• Lambert A, Schwarz L, Borbath I, et al. An update on treatment options for pancreatic adenocarcinoma. Ther Adv Med Oncol. 2019;11:1758835919875568.
   Web of Science ®Google Scholar
• Bhosale P, Cox V, Faria S, et al. Genetics of pancreatic cancer and implications for therapy. Abdom Radiol (NY). 2018 Feb;43(2):404–414. .
   PubMed Web of Science ®Google Scholar
• Mishra S, Yadav T, Rani V. Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol. 2016 Feb;98:12–23.
   PubMed Web of Science ®Google Scholar
• Qadir MI, Faheem A. miRNA: a diagnostic and therapeutic tool for pancreatic cancer. Crit Rev Eukaryot Gene Expr. 2017;27(3):197–204.
   PubMed Web of Science ®Google Scholar
• An N, Zheng B. MiR-203a-3p inhibits pancreatic cancer cell proliferation, EMT, and apoptosis by regulating SLUG. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033819898729.
   Web of Science ®Google Scholar
• Guo S, Fesler A, Wang H, et al. microRNA based prognostic biomarkers in pancreatic cancer. Biomark Res. 2018;6(1):18. .
   PubMedGoogle Scholar
• Karandish F, Biomarkers MS. Targeted therapy in pancreatic cancer. Biomark Cancer. 2016;8(Suppl 1):27–35.
   PubMedGoogle Scholar
• Ma J, Sun S, Song C, et al. Screening potential microRNAs associated with pancreatic cancer: data mining based on RNA sequencing and microarrays. Exp Ther Med. 2020 Sep;20(3):2705–2715.
   PubMed Web of Science ®Google Scholar
• Yue H, Liu L, Song Z. miR-212 regulated by HIF-1α promotes the progression of pancreatic cancer. Exp Ther Med. 2019 Mar;17(3):2359–2365.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu A, Feng X, et al. MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN. Prog Biophys Mol Biol. 2019 Nov;148:65–72.
   PubMed Web of Science ®Google Scholar
• Rao X, Wan L, Jie Z, et al. Upregulated miR-27a-3p indicates a poor prognosis in pancreatic carcinoma patients and promotes the angiogenesis and migration by epigenetic silencing of GATA6 and activating VEGFA/VEGFR2 signaling pathway. Onco Targets Ther. 2019;12:11241–11254.
   PubMed Web of Science ®Google Scholar
• Kim K, Yoo D, Lee HS, et al. Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs. BMC Med Genomics. 2019 May 16;12(1):62.
   PubMedGoogle Scholar
• Gao Y, Yi X, Ding Y. Combined transcriptomic analysis revealed AKR1B10 played an important role in psoriasis through the dysregulated lipid pathway and overproliferation of keratinocyte. Biomed Res Int. 2017;2017:8717369.
   Google Scholar
• Liu B, Sun X. miR-25 promotes invasion of human non-small cell lung cancer via CDH1. Bioengineered. 2019 Dec;10(1):271–281.
   PubMed Web of Science ®Google Scholar
• Su QL, Zhao HJ, Song CF, et al. MicroRNA-383 suppresses pancreatic carcinoma development via inhibition of GAB1 expression. Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10729–10739.
   PubMed Web of Science ®Google Scholar
• Ma X, Tao R, Li L, et al. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer. Oncol Rep. 2019 Jan;41(1):292–300.
   PubMed Web of Science ®Google Scholar
• Rawat M, Kadian K, Gupta Y, et al. MicroRNA in pancreatic cancer: from biology to therapeutic potential. Genes (Basel). 2019 Sep 25;10(10):752.
   PubMed Web of Science ®Google Scholar
• Wang W, Lou W, Ding B, et al. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Aging (Albany NY). 2019 May 6;11(9): 2610–2627.
   PubMedGoogle Scholar
• Sun Y, Chen G, He J, et al. Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer. Bioengineered. 2021;Dec;12(1):325–340.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhou K, Ma L, et al. MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis in vitro and in vivo. Bioengineered. 2020 Dec;11(1):219–228.
   Google Scholar
• Cheng H, Shi S, Cai X, et al. microRNA signature for human pancreatic cancer invasion and metastasis. Exp Ther Med. 2012 Aug;4(2):181–187. .
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang Y, Huang Z, et al. MiR-409-3p inhibits cell proliferation and invasion of osteosarcoma by targeting zinc-finger e-box-binding homeobox-1. Front Pharmacol. 2019;10:137.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hou W, Jia J, et al. MiR-409-3p regulates cell proliferation and tumor growth by targeting E74-like factor 2 in osteosarcoma. FEBS Open Bio. 2017 Mar;7(3):348–357.
   PubMed Web of Science ®Google Scholar
• Cao GH, Sun XL, Wu F, et al. Low expression of miR-409-3p is a prognostic marker for breast cancer. Eur Rev Med Pharmacol Sci. 2016 Sep;20(18):3825–3829.
   PubMed Web of Science ®Google Scholar
• Lin C, Hu Z, Yuan G, et al. MicroRNA-1179 inhibits the proliferation, migration and invasion of human pancreatic cancer cells by targeting E2F5. Chem Biol Interact. 2018 Aug 1;291:65–71.
   PubMed Web of Science ®Google Scholar
• Zhu CL, Huang Q. Overexpression of the SMYD3 promotes proliferation, migration, and invasion of pancreatic cancer. Dig Dis Sci. 2020 Feb;65(2):489–499.
   PubMed Web of Science ®Google Scholar
• Chen H, Dai J. miR-409-3p suppresses the proliferation, invasion and migration of tongue squamous cell carcinoma via targeting RDX. Oncol Lett. 2018 Jul;16(1):543–551.
   PubMed Web of Science ®Google Scholar
• Xu X, Chen H, Lin Y, et al. MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met. Mol Cells. 2013 Jul;36(1):62–68.
   PubMed Web of Science ®Google Scholar
• Bai R, Weng C, Dong H, et al. MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression. Int J Cancer. 2015 Nov 15;137(10):2310–2322.
   PubMed Web of Science ®Google Scholar